Abstract:BACKGROUND:Recent studies show that mutations in Leucine Rich Repeat Kinase 2 (LRRK2) are the cause of the most common inherited and some sporadic forms of Parkinson's disease (PD). The molecular mechanism underlying the pathogenic role of LRRK2 mutations in PD remains unknown.METHODOLOGY/PRINCIPAL FINDINGS:Using affinity purification and mass spectrometric analysis, we investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain. We identified multiple phosphorylation sites at N-terminus of LRRK2 including S910, S912, S935 and S973. Focusing on the high stoichiometry S935 phosphorylation site, we developed an anti-pS935 specific antibody and showed that LRRK2 is constitutively phosphorylated at S935 in various tissues (including brain) and at different ages in mice. We find that 14-3-3 proteins (especially isoforms γ and η) bind LRRK2 and this binding depends on phosphorylation of S935. The binding of 14-3-3, with little effect on dimer formation of LRRK2, confers protection of the phosphorylation status of S935. Furthermore, we show that protein kinase A (PKA), but not LRRK2 kinase itself, can cause the phosphorylation of LRRK2 at S935 in vitro and in cell culture, suggesting that PKA is a potential upstream kinase that regulates LRRK2 function. Finally, our study indicates that the common PD-related mutations of LRRK2, R1441G, Y1699C and G2019S, decrease homeostatic phosphorylation levels of S935 and impair 14-3-3 binding of LRRK2.CONCLUSIONS/SIGNIFICANCE:LRRK2 is extensively phosphorylated in vivo, and the phosphorylation of specific sites (e.g. S935) determines 14-3-3 binding of LRRK2. We propose that 14-3-3 is an important regulator of LRRK2-mediated cellular functions. Our study suggests that PKA, a cAMP-dependent kinase involved in regulating dopamine physiology, is a potential upstream kinase that phosphorylates LRRK2 at S935. Furthermore, the reduction of phosphorylation/14-3-3 binding of LRRK2 due to the common familial PD-related mutations provides novel insight into the pathogenic mechanism of LRRK2-linked PD.

The Parkinson's Disease-Associated Mutation LRRK2 G2385R Alters Mitochondrial Biogenesis Via the PGC-1α-TFAM Pathway.

Clinical and Functional Evidence for the Pathogenicity of the LRRK2 P.arg1067gln Variant

The LRRK2 gene is mutated in a Chinese autosomal-dominant Parkinson's disease family.

Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation

The Role of the LRRK2 Gene in Parkinsonism

LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson’s disease

ULK1 and JNK Are Involved in Mitophagy Incurred by LRRK2 G2019S Expression

Curcumin Reduced H2O2- and G2385R-LRRK2-Induced Neurodegeneration.

Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death

Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice is Eliminated by Familial Parkinson's Disease Mutation G2019S

LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1.

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease

LRRK2 G2019S Mutation Inhibits Degradation of Α-Synuclein in an in Vitro Model of Parkinson’s Disease

Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia

The Heterozygous R1441C Mutation of Leucine-Rich Repeat Kinase 2 Gene in a Chinese Patient with Parkinson Disease: A Five-Year Follow-Up and Literatures Review

LRRK2 Kinase Activity Induces Mitochondrial Fission in Microglia via Drp1 and Modulates Neuroinflammation

Phosphorylation-dependent 14-3-3 Binding to LRRK2 is Impaired by Common Mutations of Familial Parkinson's Disease.

LRRK2 Mediated Rab8a Phosphorylation Promotes Lipid Storage

Clinical Features and Mutation Analysis of LRRK2 Gene in Patients with Autosomal Dominant Familial Parkinson's Disease

Lrrk2 Gly2385arg Variant is A Risk Factor of Parkinson'S Disease among Han-Chinese from Mainland China

LRRK2 R1398H Polymorphism is Associated with Decreased Risk of Parkinson’s Disease in a Han Chinese Population